Atipam, 5.0 mg/ml, solution for injection for cats and dogs

Valsts: Īrija

Valoda: angļu

Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)

Aktīvā sastāvdaļa:

Atipamezole hydrochloride

Pieejams no:

Eurovet Animal Health B.V.

ATĶ kods:

QV03AB90

SNN (starptautisko nepatentēto nosaukumu):

Atipamezole hydrochloride

Deva:

5.0 milligram(s)/millilitre

Zāļu forma:

Solution for injection

Receptes veids:

POM: Prescription Only Medicine as defined in relevant national legislation

Ārstniecības grupa:

Cats, Dogs

Ārstniecības joma:

atipamezole

Ārstēšanas norādes:

Neurological Preparations

Autorizācija statuss:

Authorised

Autorizācija datums:

2008-05-23

Produkta apraksts

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Atipam, 5.0 mg/ml, solution for injection for cats and dogs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection.
Clear and colourless sterile aqueous solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats and dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Atipamezole hydrochloride is a selective
2-antagonist and indicated for reversal of the sedative effects of
medetomidine and dexmedetomidine in cats and dogs.
4.3 CONTRAINDICATIONS
The product should not be used in:
- Breeding animals
- Animals suffering from liver- or renal diseases
See also section 4.7.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Make sure the animal has regained a normal swallowing reflex before
any food or drink is offered.
Each ml contains:
Active ingredients
Atipamezole hydrochloride (equivalent to 4.27 mg atipamezole base)
5.0 mg
Excipients
Methyl parahydroxybenzoate (E 218)
1.0 mg
For a full list of excipients, see section 6.1.
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_7_
_/_
_0_
_6_
_/_
_2_
_0_
_1_
_3_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_3_
_3_
_2_
_3_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
After administration of
the product,
the animals should be allowed to rest
in a quiet
place.
During recovery time
animals should not be left unattended.
Due to different dosing recommendations caution should be taken if
using